AAAAAA

   
Results: 1-5 |
Results: 5
A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA (OCT-43) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: ELKORDY M CRUMP M VREDENBURGH JJ PETROS WP HUSSEIN A RUBIN P ROSS M GILBERT C MODLIN C MEISENBERG B CONIGLIO D RABINOWITZ J LAUGHLIN M KURTZBERG J PETERS WP
Citation: M. Elkordy et al., A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA (OCT-43) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(4), 1997, pp. 315-322
THE PHARMACOLOGICAL EFFECTS OF RECOMBINANT, HUMAN COLONY-STIMULATING FACTORS AND THEIR MODULATION BY THEOPHYLLINE
Authors: PETROS WP ROSNER GL RABINOWITZ J GILBERT CJ CONIGLIO D VREDENBURGH JJ ROSS M PETERS WP
Citation: Wp. Petros et al., THE PHARMACOLOGICAL EFFECTS OF RECOMBINANT, HUMAN COLONY-STIMULATING FACTORS AND THEIR MODULATION BY THEOPHYLLINE, Pharmacotherapy, 16(5), 1996, pp. 742-748
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCED IN CHINESE-HAMSTER OVARY CELLS (REGRAMOSTIM), ESCHERICHIA-COLI (MOLGRAMOSTIM) AND YEAST (SARGRAMOSTIM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY
Authors: HUSSEIN AM ROSS M VREDENBURGH J MEISENBERG B HARS V GILBERT C PETROS WP CONIGLIO D KURTZBERG J RUBIN P PETERS WP
Citation: Am. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCED IN CHINESE-HAMSTER OVARY CELLS (REGRAMOSTIM), ESCHERICHIA-COLI (MOLGRAMOSTIM) AND YEAST (SARGRAMOSTIM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, European journal of haematology, 54(5), 1995, pp. 281-287
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER
Authors: PETERS WP ROSS M VREDENBURGH JJ MEISENBERG B MARKS LB WINER E KURTZBERG J BAST RC JONES R SHPALL E WU K ROSNER G GILBERT C MATHIAS B CONIGLIO D PETROS W HENDERSON IC NORTON L WEISS RB BUDMAN D HURD D
Citation: Wp. Peters et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1132-1143
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY
Authors: HUSSEIN A ROSS M VREDENBURGH J MEISENBERG B GILBERT C PETROS W CONIGLIO D KURTZBERG J PETERS WP
Citation: A. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000293-10000293
Risultati: 1-5 |